Business

American Express Stock Falls 20% From December High as Expenses Climb

American Express shares trade near $310, about 20% below their December 2025 high, as rising expenses and slower earnings growth weigh on the stock.

Iran Sends US Peace Terms via Qatar as Oil Crosses $100 a Barrel

Iran's security chief says Tehran has sent Washington conditions to end the war through Qatar, including lifting the US naval blockade, as oil crosses $100

American Express Stock Falls 20% From December High as Expenses Climb

American Express shares trade near $310, about 20% below their December 2025 high, as rising expenses and slower earnings growth weigh on the stock.

US and China Hold Final Trade Talks Before Sept. 24 Trump-Xi Summit

Bessent, Greer and He Lifeng met in New York on Sunday to prepare for the September 24 Trump-Xi summit.

China Controls 90% of Rare Earths as Trump-Xi Summit Nears

China controls 90% of rare earths as Trump and Xi prepare to meet Thursday, with export restrictions hanging over the talks.

Aschenbrenner’s AI-Focused Hedge Fund Reportedly Sinks 67% in July Unwind

Leopold Aschenbrenner's AI-focused hedge fund reportedly dropped 67% in July, triggering a momentum-stock shakeout followed by a record snap-back rebound.

Novo Nordisk Shares Sink 10% After Heart Drug Ziltivekimab Fails Late-Stage Trial

Novo Nordisk shares fell about 10% after its experimental heart medicine ziltivekimab missed the primary goal of a key late-stage trial.

Apple Shares Slide as Supply Chain Constraints Cloud Outlook in Cook’s Final Earnings

Apple shares fell as supply chain constraints and rising memory-chip prices overshadowed strong product demand in Tim Cook's final earnings report as CEO.

Musk Rejects Report That Tesla May Sell China Business Amid SpaceX Merger Talk

Elon Musk has rejected a report that Tesla is weighing a sale of its China business amid speculation over a potential SpaceX merger.

China’s Factory Activity Slips Into Contraction in July as Export Rush Fades

China's official manufacturing PMI fell to 49.2 in July, its first contraction in five months, as the export-driven rebound loses momentum and domestic dem

Apple Posts Strongest June Quarter Ever as iPhone and Mac Sales Beat Forecasts

Apple reported record June-quarter results, beating Wall Street on iPhone and Mac sales, though services revenue missed targets and shares slipped after ho

U.S. Economy Slows to 1.5% Growth in Second Quarter as Inflation Stays Above Fed Target

The U.S. economy slowed to 1.5% growth in the second quarter as imports weighed on output, while inflation eased slightly but remained above the Fed's 2% t

Apple Stock Wavers After Landmark $5 Trillion Milestone Tests Investor Confidence

Apple shares slide shortly after reaching a historic $5 trillion market cap, as investors weigh valuation concerns and the payoff from AI spending.

Reddit Shares Fall 11% on Search Referral Worries Despite Earnings Beat

Reddit stock fell about 11% after strong quarterly earnings were overshadowed by concerns over choppy search referral traffic and AI-driven search shifts.

Anthropic Says Claude AI Models Accessed Three Firms’ Systems During Testing

Anthropic says its Claude AI models gained unauthorized access to three organizations' systems during cybersecurity tests after a misconfiguration.

Amazon Shares Surge as Cloud Growth Bolsters Case for Heavy AI Spending

Amazon shares jumped about 10% after strong AWS cloud sales and a raised capital spending plan reassured investors on its heavy AI investment.

CXMT Becomes China’s Most Valuable Listed Company After Explosive Shanghai Debut

Memory chip maker CXMT surged 466% in its Shanghai debut, reaching a $592 billion valuation and becoming China's most valuable listed company.

Apple’s Hybrid AI Strategy Is a ‘Competitive Weapon,’ Tim Cook Says

Tim Cook calls Apple's hybrid AI approach a competitive weapon and warns that a full Siri overhaul in China will roll out gradually amid a memory shortage.

Regeneron Shares Climb as Eczema Drug Dupixent Powers Quarterly Earnings Beat

Regeneron Pharmaceuticals shares climbed after quarterly results topped estimates, powered by strong sales of its eczema drug Dupixent.

- A word from our sponsors -

spot_img

Follow us

HomeBusiness